SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gland Pharma informs about analyst meet

15 Dec 2021 Evaluate
Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Gland Pharma has informed that it enclosed the schedule of Analyst/ Institutional Investor Meeting with the Company as on 17th December 2021.

The above information is a part of company’s filings submitted to BSE.

Gland Pharma Share Price

1795.30 13.15 (0.74%)
22-Apr-2026 14:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1664.60
Dr. Reddys Lab 1219.10
Cipla 1236.00
Zydus Lifesciences 931.55
Lupin 2301.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×